Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBTF like 3 (UBTFL3) is annotated as a pseudogene in the human genome (GeneID: 129870)[3][7]. This locus is predicted to be a non-functional remnant of gene duplication or retrotransposition and does not produce a functional protein. The gene is described as containing a high mobility group (HMG) box motif, but unlike its functional counterparts (such as UBTF), it has no known biological activity, protein product, or therapeutic relevance. The functional gene UBTF (upstream binding transcription factor) encodes a transcription factor that binds ribosomal DNA and is critical for ribosomal RNA transcription by RNA polymerase I, but UBTFL3 itself is not a functional transcription factor[3][4][6]. Key distinctions: UBTF like 3 (UBTFL3) should not be confused with the upstream binding transcription factor (UBTF), which is a biologically active protein involved in transcription regulation[5]. UBTFL3 is not a therapeutic target, has no protein product, is not part of any known disease mechanism, and is not referenced as a biomarker or involved in any drug interactions[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Upstream binding transcription factor, RNA polymerase I-like 3 (pseudogene) (UBTFL3).